Please login to the form below

Not currently logged in
Email:
Password:

Novasecta

This page shows the latest Novasecta news and features for those working in and with pharma, biotech and healthcare.

Taming the Monster

Taming the Monster

Many companies still struggle to see the value that marketing brings,” says Ed Corbett, principal, Novasecta.

Latest news

  • Keeping it in the family pays dividends Keeping it in the family pays dividends

    Gold rush. Novasecta also believes that serial acquisition is not always a Holy Grail. ... Novasecta research showed that the cost of acquisitions doubled in 2016 compared to the previous year, with the median value of the acquisition running at 39 times

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Practical Patient Centricity

    Putting customers at the centre of businesses is common practice in many industry sectors. Though the pharmaceutical industry has multiple customers, including healthcare professionals and payors, the ultimate customers are always patients. For many

  • Digital Marketing is no Substitute for Sound Strategic Marketing

    Novasecta’s experience is that at some level, all companies are flexing their digital muscles – with some more than others. ... Novasecta’s experience is that for companies with a heritage in strong strategic marketing, re-building the marketing

  • Novasecta Novasecta

    We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance improvement and sustainable growth by working with their leaders and teams to develop excellent

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...